Glucagon-Like Peptide-1 Receptor Agonists for Treatment of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis: An Updated Meta-Analysis of Randomized Controlled Trials

To assess the efficacy of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) for treatment of nonalcoholic fatty liver disease (NAFLD) or steatohepatitis (NASH), we performed a systematic review and meta-analysis of randomized controlled trials (RCTs). Three large electronic databases were system...

Descripción completa

Detalles Bibliográficos
Autores principales: Mantovani, Alessandro, Petracca, Graziana, Beatrice, Giorgia, Csermely, Alessandro, Lonardo, Amedeo, Targher, Giovanni
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7911747/
https://www.ncbi.nlm.nih.gov/pubmed/33513761
http://dx.doi.org/10.3390/metabo11020073

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7911747/
https://www.ncbi.nlm.nih.gov/pubmed/33513761
http://dx.doi.org/10.3390/metabo11020073

Ejemplares similares